The Role of RNA in HIV-1 Vif-Mediated Degradation of APOBEC3H

被引:3
|
作者
Wang, Jiayi [1 ,2 ,3 ,4 ]
Becker, Jordan T. [1 ,2 ,3 ,4 ]
Shi, Ke [1 ,2 ,3 ]
Lauer, Kate V. [1 ,2 ,3 ,4 ]
Salamango, Daniel J. [1 ,2 ,3 ,4 ]
Aihara, Hideki [1 ,2 ,3 ]
Shaban, Nadine M. [1 ,2 ,3 ,4 ]
Harris, Reuben S. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA
关键词
APOBEC3H; DNA cytosine deaminase; HIV-1; Vif; Subcellular localization; Vif-APOBEC interaction; EDITING ENZYME APOBEC3G; REVERSE TRANSCRIPTION; RESTRICTION FACTORS; ANTIVIRAL ACTIVITY; P-BODIES; 7SL RNA; VIRIONS; LOCALIZATION; VARIANTS; PROTEIN;
D O I
10.1016/j.jmb.2019.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As many as five members of the APOBEC3 family of DNA cytosine deaminases are capable of inhibiting HIV-1 replication by deaminating viral cDNA cytosines and interfering with reverse transcription. HIV-1 counteracts restriction with the virally encoded Vif protein, which forms a hybrid ubiquitin ligase complex that directly binds APOBEC3 enzymes and targets them for proteasomal degradation. APOBEC3H (A3H) is unique among family members by dimerization through cellular and viral duplex RNA species. RNA binding is required for localization of A3H to the cytoplasmic compartment, for efficient packaging into nascent HIV-1 particles and ultimately for effective virus restriction activity. Here we compared wild-type human A3H and RNA binding-defective mutants to ask whether RNA may be a factor in the functional interaction with HIV-1 Vif. We used structural modeling, immunoblotting, live cell imaging, and split green fluorescence protein (GFP) reconstitution approaches to assess the capability of HIV-1 Vif to promote the degradation of wild-type A3H in comparison to RNA binding-defective mutants. The results combined to show that RNA is not strictly required for Vif-mediated degradation of A3H, and that RNA and Vif are likely to bind this single-domain DNA cytosine deaminase on physically distinct surfaces. However, a subset of the results also indicated that the A3H degradation process may be affected by A3H protein structure, subcellular localization, and differences in the constellation of A3H interaction partners, suggesting additional factors may also influence the fate and functionality of this host-pathogen interaction. (C) 2019 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:5019 / 5031
页数:13
相关论文
共 50 条
  • [41] Biochemical Characterization of APOBEC3H Variants: Implications for Their HIV-1 Restriction Activity and mC Modification
    Gu, Jiang
    Chen, Qihan
    Xiao, Xiao
    Ito, Fumiaki
    Wolfe, Aaron
    Chen, Xiaojiang S.
    JOURNAL OF MOLECULAR BIOLOGY, 2016, 428 (23) : 4626 - 4638
  • [42] Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta
    Miyagi, Eri
    Welbourn, Sarah
    Sukegawa, Sayaka
    Fabryova, Helena
    Kao, Sandra
    Strebel, Klaus
    JOURNAL OF VIROLOGY, 2020, 94 (07)
  • [43] Structural Insights into HIV-1 Vif-APOBEC3F Interaction
    Nakashima, Masaaki
    Ode, Hirotaka
    Kawamura, Takashi
    Kitamura, Shingo
    Naganawa, Yuriko
    Awazu, Hiroaki
    Tsuzuki, Shinya
    Matsuoka, Kazuhiro
    Nemoto, Michiko
    Hachiya, Atsuko
    Sugiura, Wataru
    Yokomaku, Yoshiyuki
    Watanabe, Nobuhisa
    Iwatani, Yasumasa
    JOURNAL OF VIROLOGY, 2016, 90 (02) : 1034 - 1047
  • [44] HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
    Marin, M
    Rose, KM
    Kozak, SL
    Kabat, D
    NATURE MEDICINE, 2003, 9 (11) : 1398 - 1403
  • [45] HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
    Mariana Marin
    Kristine M Rose
    Susan L Kozak
    David Kabat
    Nature Medicine, 2003, 9 : 1398 - 1403
  • [46] Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
    Kouno, Takahide
    Shibata, Satoshi
    Shigematsu, Megumi
    Hyun, Jaekyung
    Kim, Tae Gyun
    Matsuo, Hiroshi
    Wolf, Matthias
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [47] Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G
    Takahide Kouno
    Satoshi Shibata
    Megumi Shigematsu
    Jaekyung Hyun
    Tae Gyun Kim
    Hiroshi Matsuo
    Matthias Wolf
    Nature Communications, 14
  • [48] Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
    Doehle, BP
    Schäfer, A
    Cullen, BR
    VIROLOGY, 2005, 339 (02) : 281 - 288
  • [49] Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease
    Ebrahimi, Diako
    Richards, Christopher M.
    Carpenter, Michael A.
    Wang, Jiayi
    Ikeda, Terumasa
    Becker, Jordan T.
    Cheng, Adam Z.
    McCann, Jennifer L.
    Shaban, Nadine M.
    Salamango, Daniel J.
    Starrett, Gabriel J.
    Lingappa, Jairam R.
    Yong, Jeongsik
    Brown, William L.
    Harris, Reuben S.
    NATURE COMMUNICATIONS, 2018, 9
  • [50] Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease
    Diako Ebrahimi
    Christopher M. Richards
    Michael A. Carpenter
    Jiayi Wang
    Terumasa Ikeda
    Jordan T. Becker
    Adam Z. Cheng
    Jennifer L. McCann
    Nadine M. Shaban
    Daniel J. Salamango
    Gabriel J. Starrett
    Jairam R. Lingappa
    Jeongsik Yong
    William L. Brown
    Reuben S. Harris
    Nature Communications, 9